Haynes. 1975. Mumps meningoencephalitis. Prolonged
abnormality of cerebrospinal fluid. J. Am. Med. Assoc.
234: 1161-1162.
2. Felgenhauer, K. 1974. Protein size and cerebrospinal
fluid composition. Klin. Wschr. 52:1158-1164.
3. Fryden, A. 1977. B and T lymphocytes in blood and
cerebrospinal fluid in aseptic meningitis. Scand. J. Im- munol. 6:1283-1288.
4. Fryden, A., and H. Link. 1978. Mitogen stimulation of
cerebrospinal fluid lymphocytes in aseptic meningitis.
Acta Neurol. Scand. 57:8-18.
5. Fryden, A., H. Link, and E. Molier. 1978. Demonstration of CSF lymphocytes sensitized against virus antigens in mumps meningitis. Acta Neurol. Scand.
57:396-404.
6. Hapel, A. J. 1975. The protective role of thymusderived
lymphocytes in arbovirus-induced meningoencephalitis.
Scand. J. Immunol. 4:267-278.
7. Hapel, A. J., and I. Gardner. 1974. Appearance of
cytotoxic T cells in cerebrospinal fluid of mice with
ectromelia virus-induced meningitis. Scand. J. Immunol. 3:311-319.
8. Jersild, 0., T. Fog, G. S. Hansen, M. Thomsen, A.
Svejgaard, and B. Dupont. 1973. Histocompatibility
determinants in multiple sclerosis with special reference
to clinical course. Lancet ii:1221-1225.
9. Laterre, E. C., A. Callewaert, J. A. Heremans, and Z.
Sfaello. 1970. Electrophoretic morphology of gamma
globulins in cerebrospinal fluid of multiple sclerosis and
other diseases of the central nervous system. Neurology
20:982-990.
10. Levinson, A. I., R. P. Lisak, and B. Zweiman. 1976.
Immunologic characterization of cerebrospinal fluid
lymphocytes: preliminary report. Neurology 26:
693-695.
11. Lindbak, H., S. Halvorsen, O.-J. Julsrud, and S.
Skandeen. 1974. Agarose gel electroforese av spinal
vaeske. Tidsskr. Nor. Laegeforen. 94:152-155.
12. Link, H. 1967. Immunoglobulin G and low molecular
weight proteins in human cerebrospinal fluid. Chemical
and immunological characterization with special reference to multiple sclerosis. Acta Neurol. Scand.
28(Suppl.):1-136.
13. Link, H. 1973. Comparison of electrophoresis on agar gel
and agarose gel in the evaluation of gamma-globulin
abnormalities in cerebrospinal fluid and serum in multiple sclerosis. Clin. Chim. Acta 46:383-389.
14. -ink, H., and R. Miller. 1971. Immunoglobulins in multiple sclerosis and infections of the nervous system.
Arch. Neurol. 25:326-343.
15. Link, H., and G. Tibbling. 1977. Principles of albumin
and IgG analyses in neurological disorders. II. Relation
of the concentration of the proteins in serum and cerebrospinal fluid. Scand. J. Clin. Lab. Invest. 37:391-396.
16. Link, H., and G. Tibbling. 1977. Principles of albumin
and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system
in multiple sclerosis. Scand. J. Clin. Lab. Invest.
37:397-401.
17. Link, H., and 0. Zettervall. 1970. Multiple sclerosis:
disturbed kappa/lambda light chain ratio of immunoglobulin G in cerebrospinal fluid. Clin. Exp. Immunol.
6:435-438.
18. Link, H., 0. Zettervall, and G. Blennow. 1972. Individual cerebrospinal fluid (CSF) proteins in the evaluation
of increased CSF total protein. Z. Neurol. 203:119-132.
19. Lowry, 0. H., N. J. Rosebrough, A. L. Farr, and R. J.
Randall. 1951. Protein measurement with the Folin
phenol reagent. J. Biol. Chem. 193:265-275.
20. Mancini, G., J. P. Vaerman, A. O. Carbonara, and J.
F. Heremans. 1964. A single-radial-diffusion method
for immunological quantification of proteins, p. 370. In
H. Peters (ed.), XI colloquium on protides of the
